Familial cancer associated with a polymorphism in ARLTS1

George Adrian Calin, Francesco Trapasso, Masayoshi Shimizu, Calin Dan Dumitru, Sai Yendamuri, Andrew K. Godwin, Manuela Ferracin, Guido Bernardi, Devjani Chatterjee, Gustavo Baldassarre, Shashi Rattan, Hansjuerg Alder, Hideaki Mabuchi, Takeshi Shiraishi, Lise Lotte Hansen, Jens Overgaard, Vlad Herlea, Francesca Romana Mauro, Guillaume Dighiero, Benjamin MovsasLaura Rassenti, Thomas Kipps, Raffaele Baffa, Alfredo Fusco, Masaki Mori, Giandomenico Russo, Chang Gong Liu, Donna Neuberg, Florencia Bullrich, Massimo Negrini, Carlo M. Croce

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

BACKGROUND: The finding of hemizygous or homozygous deletions at band 14 on chromosome 13 in a variety of neoplasms suggests the presence of a tumor-suppressor locus telomeric to the RB1 gene. METHODS: We studied samples from 216 patients with various types of sporadic tumors or idiopathic pancytopenia, peripheral-blood samples from 109 patients with familial cancer or multiple cancers, and control blood samples from 475 healthy people or patients with diseases other than cancer. We performed functional studies of cell lines lacking ARLTS1 expression with the use of both the full-length ARLTS1 gene and a truncated variant. RESULTS: We found a gene at 13q14, ARLTS1, a member of the ADP-ribosylation factor family, with properties of a tumor-suppressor gene. We analyzed 800 DNA samples from tumors and blood cells from patients with sporadic or familial cancer and controls and found that the frequency of a nonsense polymorphism, G446A (Trp149Stop), was similar in controls and patients with sporadic tumors but was significantly more common among patients with familial cancer than among those in the other two groups (P=0.02; odds ratio, 5.7; 95 percent confidence interval, 1.3 to 24.8). ARLTS1 was down-regulated by promoter methylation in 25 percent of the primary tumors we analyzed. Transfection of wild-type ARLTS1 into A549 lung-cancer cells suppressed tumor formation in immunodeficient mice and induced apoptosis, whereas transfection of truncated ARLTS1 had a limited effect on apoptosis and tumor suppression. Microarray analysis revealed that the wild-type and Trp149Stop-transfected clones had different expression profiles. CONCLUSIONS: A genetic variant of ARLTS1 predisposes patients to familial cancer.

Original languageEnglish
Pages (from-to)1667-1676
Number of pages10
JournalNew England Journal of Medicine
Volume352
Issue number16
DOIs
Publication statusPublished - Apr 21 2005

Fingerprint

Neoplasms
Transfection
ADP-Ribosylation Factors
Apoptosis
Genes
Chromosomes, Human, Pair 13
Pancytopenia
Microarray Analysis
Tumor Suppressor Genes
Methylation
Lung Neoplasms
Blood Cells
Clone Cells
Odds Ratio
Confidence Intervals
Cell Line
DNA

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Calin, G. A., Trapasso, F., Shimizu, M., Dumitru, C. D., Yendamuri, S., Godwin, A. K., ... Croce, C. M. (2005). Familial cancer associated with a polymorphism in ARLTS1. New England Journal of Medicine, 352(16), 1667-1676. https://doi.org/10.1056/NEJMoa042280

Familial cancer associated with a polymorphism in ARLTS1. / Calin, George Adrian; Trapasso, Francesco; Shimizu, Masayoshi; Dumitru, Calin Dan; Yendamuri, Sai; Godwin, Andrew K.; Ferracin, Manuela; Bernardi, Guido; Chatterjee, Devjani; Baldassarre, Gustavo; Rattan, Shashi; Alder, Hansjuerg; Mabuchi, Hideaki; Shiraishi, Takeshi; Hansen, Lise Lotte; Overgaard, Jens; Herlea, Vlad; Mauro, Francesca Romana; Dighiero, Guillaume; Movsas, Benjamin; Rassenti, Laura; Kipps, Thomas; Baffa, Raffaele; Fusco, Alfredo; Mori, Masaki; Russo, Giandomenico; Liu, Chang Gong; Neuberg, Donna; Bullrich, Florencia; Negrini, Massimo; Croce, Carlo M.

In: New England Journal of Medicine, Vol. 352, No. 16, 21.04.2005, p. 1667-1676.

Research output: Contribution to journalArticle

Calin, GA, Trapasso, F, Shimizu, M, Dumitru, CD, Yendamuri, S, Godwin, AK, Ferracin, M, Bernardi, G, Chatterjee, D, Baldassarre, G, Rattan, S, Alder, H, Mabuchi, H, Shiraishi, T, Hansen, LL, Overgaard, J, Herlea, V, Mauro, FR, Dighiero, G, Movsas, B, Rassenti, L, Kipps, T, Baffa, R, Fusco, A, Mori, M, Russo, G, Liu, CG, Neuberg, D, Bullrich, F, Negrini, M & Croce, CM 2005, 'Familial cancer associated with a polymorphism in ARLTS1', New England Journal of Medicine, vol. 352, no. 16, pp. 1667-1676. https://doi.org/10.1056/NEJMoa042280
Calin GA, Trapasso F, Shimizu M, Dumitru CD, Yendamuri S, Godwin AK et al. Familial cancer associated with a polymorphism in ARLTS1. New England Journal of Medicine. 2005 Apr 21;352(16):1667-1676. https://doi.org/10.1056/NEJMoa042280
Calin, George Adrian ; Trapasso, Francesco ; Shimizu, Masayoshi ; Dumitru, Calin Dan ; Yendamuri, Sai ; Godwin, Andrew K. ; Ferracin, Manuela ; Bernardi, Guido ; Chatterjee, Devjani ; Baldassarre, Gustavo ; Rattan, Shashi ; Alder, Hansjuerg ; Mabuchi, Hideaki ; Shiraishi, Takeshi ; Hansen, Lise Lotte ; Overgaard, Jens ; Herlea, Vlad ; Mauro, Francesca Romana ; Dighiero, Guillaume ; Movsas, Benjamin ; Rassenti, Laura ; Kipps, Thomas ; Baffa, Raffaele ; Fusco, Alfredo ; Mori, Masaki ; Russo, Giandomenico ; Liu, Chang Gong ; Neuberg, Donna ; Bullrich, Florencia ; Negrini, Massimo ; Croce, Carlo M. / Familial cancer associated with a polymorphism in ARLTS1. In: New England Journal of Medicine. 2005 ; Vol. 352, No. 16. pp. 1667-1676.
@article{7f06560622c44fbeb184e1e933fd3bfe,
title = "Familial cancer associated with a polymorphism in ARLTS1",
abstract = "BACKGROUND: The finding of hemizygous or homozygous deletions at band 14 on chromosome 13 in a variety of neoplasms suggests the presence of a tumor-suppressor locus telomeric to the RB1 gene. METHODS: We studied samples from 216 patients with various types of sporadic tumors or idiopathic pancytopenia, peripheral-blood samples from 109 patients with familial cancer or multiple cancers, and control blood samples from 475 healthy people or patients with diseases other than cancer. We performed functional studies of cell lines lacking ARLTS1 expression with the use of both the full-length ARLTS1 gene and a truncated variant. RESULTS: We found a gene at 13q14, ARLTS1, a member of the ADP-ribosylation factor family, with properties of a tumor-suppressor gene. We analyzed 800 DNA samples from tumors and blood cells from patients with sporadic or familial cancer and controls and found that the frequency of a nonsense polymorphism, G446A (Trp149Stop), was similar in controls and patients with sporadic tumors but was significantly more common among patients with familial cancer than among those in the other two groups (P=0.02; odds ratio, 5.7; 95 percent confidence interval, 1.3 to 24.8). ARLTS1 was down-regulated by promoter methylation in 25 percent of the primary tumors we analyzed. Transfection of wild-type ARLTS1 into A549 lung-cancer cells suppressed tumor formation in immunodeficient mice and induced apoptosis, whereas transfection of truncated ARLTS1 had a limited effect on apoptosis and tumor suppression. Microarray analysis revealed that the wild-type and Trp149Stop-transfected clones had different expression profiles. CONCLUSIONS: A genetic variant of ARLTS1 predisposes patients to familial cancer.",
author = "Calin, {George Adrian} and Francesco Trapasso and Masayoshi Shimizu and Dumitru, {Calin Dan} and Sai Yendamuri and Godwin, {Andrew K.} and Manuela Ferracin and Guido Bernardi and Devjani Chatterjee and Gustavo Baldassarre and Shashi Rattan and Hansjuerg Alder and Hideaki Mabuchi and Takeshi Shiraishi and Hansen, {Lise Lotte} and Jens Overgaard and Vlad Herlea and Mauro, {Francesca Romana} and Guillaume Dighiero and Benjamin Movsas and Laura Rassenti and Thomas Kipps and Raffaele Baffa and Alfredo Fusco and Masaki Mori and Giandomenico Russo and Liu, {Chang Gong} and Donna Neuberg and Florencia Bullrich and Massimo Negrini and Croce, {Carlo M.}",
year = "2005",
month = "4",
day = "21",
doi = "10.1056/NEJMoa042280",
language = "English",
volume = "352",
pages = "1667--1676",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "16",

}

TY - JOUR

T1 - Familial cancer associated with a polymorphism in ARLTS1

AU - Calin, George Adrian

AU - Trapasso, Francesco

AU - Shimizu, Masayoshi

AU - Dumitru, Calin Dan

AU - Yendamuri, Sai

AU - Godwin, Andrew K.

AU - Ferracin, Manuela

AU - Bernardi, Guido

AU - Chatterjee, Devjani

AU - Baldassarre, Gustavo

AU - Rattan, Shashi

AU - Alder, Hansjuerg

AU - Mabuchi, Hideaki

AU - Shiraishi, Takeshi

AU - Hansen, Lise Lotte

AU - Overgaard, Jens

AU - Herlea, Vlad

AU - Mauro, Francesca Romana

AU - Dighiero, Guillaume

AU - Movsas, Benjamin

AU - Rassenti, Laura

AU - Kipps, Thomas

AU - Baffa, Raffaele

AU - Fusco, Alfredo

AU - Mori, Masaki

AU - Russo, Giandomenico

AU - Liu, Chang Gong

AU - Neuberg, Donna

AU - Bullrich, Florencia

AU - Negrini, Massimo

AU - Croce, Carlo M.

PY - 2005/4/21

Y1 - 2005/4/21

N2 - BACKGROUND: The finding of hemizygous or homozygous deletions at band 14 on chromosome 13 in a variety of neoplasms suggests the presence of a tumor-suppressor locus telomeric to the RB1 gene. METHODS: We studied samples from 216 patients with various types of sporadic tumors or idiopathic pancytopenia, peripheral-blood samples from 109 patients with familial cancer or multiple cancers, and control blood samples from 475 healthy people or patients with diseases other than cancer. We performed functional studies of cell lines lacking ARLTS1 expression with the use of both the full-length ARLTS1 gene and a truncated variant. RESULTS: We found a gene at 13q14, ARLTS1, a member of the ADP-ribosylation factor family, with properties of a tumor-suppressor gene. We analyzed 800 DNA samples from tumors and blood cells from patients with sporadic or familial cancer and controls and found that the frequency of a nonsense polymorphism, G446A (Trp149Stop), was similar in controls and patients with sporadic tumors but was significantly more common among patients with familial cancer than among those in the other two groups (P=0.02; odds ratio, 5.7; 95 percent confidence interval, 1.3 to 24.8). ARLTS1 was down-regulated by promoter methylation in 25 percent of the primary tumors we analyzed. Transfection of wild-type ARLTS1 into A549 lung-cancer cells suppressed tumor formation in immunodeficient mice and induced apoptosis, whereas transfection of truncated ARLTS1 had a limited effect on apoptosis and tumor suppression. Microarray analysis revealed that the wild-type and Trp149Stop-transfected clones had different expression profiles. CONCLUSIONS: A genetic variant of ARLTS1 predisposes patients to familial cancer.

AB - BACKGROUND: The finding of hemizygous or homozygous deletions at band 14 on chromosome 13 in a variety of neoplasms suggests the presence of a tumor-suppressor locus telomeric to the RB1 gene. METHODS: We studied samples from 216 patients with various types of sporadic tumors or idiopathic pancytopenia, peripheral-blood samples from 109 patients with familial cancer or multiple cancers, and control blood samples from 475 healthy people or patients with diseases other than cancer. We performed functional studies of cell lines lacking ARLTS1 expression with the use of both the full-length ARLTS1 gene and a truncated variant. RESULTS: We found a gene at 13q14, ARLTS1, a member of the ADP-ribosylation factor family, with properties of a tumor-suppressor gene. We analyzed 800 DNA samples from tumors and blood cells from patients with sporadic or familial cancer and controls and found that the frequency of a nonsense polymorphism, G446A (Trp149Stop), was similar in controls and patients with sporadic tumors but was significantly more common among patients with familial cancer than among those in the other two groups (P=0.02; odds ratio, 5.7; 95 percent confidence interval, 1.3 to 24.8). ARLTS1 was down-regulated by promoter methylation in 25 percent of the primary tumors we analyzed. Transfection of wild-type ARLTS1 into A549 lung-cancer cells suppressed tumor formation in immunodeficient mice and induced apoptosis, whereas transfection of truncated ARLTS1 had a limited effect on apoptosis and tumor suppression. Microarray analysis revealed that the wild-type and Trp149Stop-transfected clones had different expression profiles. CONCLUSIONS: A genetic variant of ARLTS1 predisposes patients to familial cancer.

UR - http://www.scopus.com/inward/record.url?scp=20244379702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20244379702&partnerID=8YFLogxK

U2 - 10.1056/NEJMoa042280

DO - 10.1056/NEJMoa042280

M3 - Article

C2 - 15843669

AN - SCOPUS:20244379702

VL - 352

SP - 1667

EP - 1676

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 16

ER -